Capricorn Technologies GmbH

Exhibitor

Capricorn Technologies GmbH is a leading biotechnology company specializing in innovative research and development for the global vaccine industry. With a strong focus on R&D and strategic partnering, we are dedicated to advancing the field of vaccine technology to address the world's most pressing public health challenges. Our team of experts is committed to developing cutting-edge vaccine solutions that are safe, effective, and accessible to populations worldwide.

At Capricorn Technologies GmbH, we leverage the latest scientific advancements and technological tools to drive innovation in vaccine development. Our collaborative approach to strategic partnering allows us to work closely with industry partners, research institutions, and government agencies to accelerate the translation of scientific discoveries into impactful vaccine products. By fostering strategic collaborations, we aim to enhance the efficiency and effectiveness of vaccine development processes, ultimately leading to the timely delivery of life-saving vaccines to those in need.

With our new prophylactic influenza vaccine platform technology UniFluVec(R), Capricorn Technologies GmbH is at the forefront of driving positive change in global public health. UniFluVec is a live attenuated recombinant influenza vaccine candidate designed to enhance mucosal immunity and provide broad cross-protective responses after intranasal administration. Our Phase 1 randomized, double-blind, placebocontrolled trial evaluated its safety and tolerability in healthy adults. (https://doi.org/10.18527/20251216879). We would like to meet potential partners at the World Vaccine Congress Washington 2026 to learn more about strategic partnering opportunities.